Difference between revisions of "Factor VIII, human"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replacement - "Category:Drug index" to "Category:Drugs")
m (Text replacement - "please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [https://online.lexi.com/lco/action/login UpToDate Lexidrug], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information" to "please refer to your preferred pharmacopeias or the prescribing information")
 
(4 intermediate revisions by 3 users not shown)
Line 1: Line 1:
 
==General information==
 
==General information==
 
Class/mechanism: Factor VIII; replaces the missing clotting factor VIII that is required for hemostasis in patients with hemophilia A.<br>Please choose from the products below to find specific drug/manufacturer information:
 
Class/mechanism: Factor VIII; replaces the missing clotting factor VIII that is required for hemostasis in patients with hemophilia A.<br>Please choose from the products below to find specific drug/manufacturer information:
*Hemofil-M<ref>[http://www.baxter.com.pr/healthcare_professionals/products/hemofil_m.html Hemofil-M manufacturer's website]</ref><ref name="Hemofil">[http://www.shirecontent.com/PI/PDFs/HEMOFILM_USA_ENG.pdf Factor VIII, human (Hemofil-M) package insert]</ref><ref>[[Media:Factorviiihemofil.pdf | Factor VIII, human (Hemofil-M) package insert (locally hosted backup)]]</ref>
+
*Hemofil-M<ref>[http://www.baxter.com.pr/healthcare_professionals/products/hemofil_m.html Hemofil-M manufacturer's website]</ref><ref name="Hemofil">[http://www.shirecontent.com/PI/PDFs/HEMOFILM_USA_ENG.pdf Factor VIII, human (Hemofil-M) package insert]</ref><ref>[[File:Factorviiihemofil.pdf | Factor VIII, human (Hemofil-M) package insert (locally hosted backup)]]</ref>
*Koate-DVI<ref>[http://www.koate-dvi.com/ Koate-DVI manufacturer's website]</ref><ref name="Koate">[http://www.koate-dvi.com/documents/809754/0/Koate_DVI.pdf/fb455459-5ac0-43d3-bb48-363389a7c5c3 Factor VIII, human (Koate-DVI) package insert]</ref><ref>[[Media:Factorviiikoate.pdf | Factor VIII, human (Koate-DVI) package insert (locally hosted backup)]]</ref>
+
*Koate-DVI<ref>[http://www.koate-dvi.com/ Koate-DVI manufacturer's website]</ref><ref name="Koate">[http://www.koate-dvi.com/documents/809754/0/Koate_DVI.pdf/fb455459-5ac0-43d3-bb48-363389a7c5c3 Factor VIII, human (Koate-DVI) package insert]</ref><ref>[[File:Factorviiikoate.pdf | Factor VIII, human (Koate-DVI) package insert (locally hosted backup)]]</ref>
*Monarc-M<ref name="Monarc">[http://www.abopharmaceuticals.com/ProductSheets/MONARC-M_PInew.pdf Factor VIII, human (Monarc-M) package insert]</ref><ref>[[Media:Factorviiimonarc.pdf | Factor VIII, human (Monarc-M) package insert (locally hosted backup)]]</ref>
+
*Monarc-M<ref name="Monarc">[http://www.abopharmaceuticals.com/ProductSheets/MONARC-M_PInew.pdf Factor VIII, human (Monarc-M) package insert]</ref><ref>[[File:Factorviiimonarc.pdf | Factor VIII, human (Monarc-M) package insert (locally hosted backup)]]</ref>
*Monoclate-P<ref>[http://www.cslbehring-us.com/products/Monoclate-P.htm Monoclate-P manufacturer's website]</ref><ref name="Monoclate">[http://labeling.cslbehring.com/PI/US/Monoclate-P/EN/Monoclate-P-Prescribing-Information.pdf Factor VIII, human (Monoclate-P) package insert]</ref><ref>[[Media:Factorviiimonoclate.pdf | Factor VIII, human (Monoclate-P) package insert (locally hosted backup)]]</ref>
+
*Monoclate-P<ref>[http://www.cslbehring-us.com/products/Monoclate-P.htm Monoclate-P manufacturer's website]</ref><ref name="Monoclate">[http://labeling.cslbehring.com/PI/US/Monoclate-P/EN/Monoclate-P-Prescribing-Information.pdf Factor VIII, human (Monoclate-P) package insert]</ref><ref>[[File:Factorviiimonoclate.pdf | Factor VIII, human (Monoclate-P) package insert (locally hosted backup)]]</ref>
 
Route: IV
 
Route: IV
 
<br>Extravasation: no information
 
<br>Extravasation: no information
  
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.
+
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias or the prescribing information.
  
 
==Diseases for which it is used==
 
==Diseases for which it is used==
Line 20: Line 20:
 
<references/>
 
<references/>
  
[[Category:Drugs]]
+
[[Category:Fractionated plasma products]]
 
[[Category:Intravenous medications]]
 
[[Category:Intravenous medications]]
  
 +
[[Category:Inherited coagulopathy medications]]
 
[[Category:Hematology medications]]
 
[[Category:Hematology medications]]
 
[[Category:Hemostasis medications]]
 
[[Category:Hemostasis medications]]
[[Category:Fractionated plasma products]]
 
 
[[Category:Coagulation factors]]
 
[[Category:Coagulation factors]]

Latest revision as of 00:57, 29 June 2024

General information

Class/mechanism: Factor VIII; replaces the missing clotting factor VIII that is required for hemostasis in patients with hemophilia A.
Please choose from the products below to find specific drug/manufacturer information:

Route: IV
Extravasation: no information

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias or the prescribing information.

Diseases for which it is used

  • Hemophilia A

Also known as

  • Generic name: coagulation factor 8
  • Brand names: Hemofil-M, Koate-DVI, Koate-HP, Monarc-M, Monoclate-P

References